Lifeforce Cryobanks
Lifeforce Cryobanks (operating as Cord for Life) is an Orlando-based private cord blood and cord tissue stem cell cryobank founded in 1995. It serves expectant parents with private family banking and public donation services using its proprietary PREMIERMAX® processing method at its FDA-accredited in-house laboratory.
- Company typePrivate
- Founded1995
- HeadquartersOrlando, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Lifeforce Cryobanks does
Lifeforce Cryobanks, operating as Cord for Life, is a private U.S. cord blood and cord tissue stem cell cryobank headquartered in Orlando, Florida, that has been continuously operating since 1995. The company collects, processes, and cryopreserves newborn stem cells from umbilical cord blood and cord tissue for two distinct pathways: private family banking (subscription-based storage for personal/family use) and public donation (inventory contributed to the national transplant registry with revenue from transplant matching). It also operates an Imminent Need Program for families with a member diagnosed with a stem-cell-treatable disease.
The company's core technology is its proprietary PREMIERMAX® processing method, which it describes as research-proven to deliver highly functional stem cells, supported by in-house laboratory operations rather than outsourced processing and a 5-chamber storage bag that allows multiple therapeutic doses from a single unit. It is accredited by the FDA and various state agencies and operates a single domestic facility in Orlando serving the Southeast U.S. market. The company claims to have facilitated over 2,200 cord blood transplants since founding — more than any other private cord blood bank — and asserts 30-year stem cell viability based on its continuous storage history.
Revenue mechanics are anchored in recurring annual storage fees from private banking subscribers, supplemented by transaction-based fees from public-bank transplant matches and subsidized enrollment through the Imminent Need Program. Go-to-market is direct-to-consumer via online enrollment and phone support, supplemented by OBGYN and midwife referral channels that distribute collection kits. Pricing is not publicly disclosed; customers receive quotes on enrollment. As of 2024, the company has begun repositioning its inventory through an FDA-authorized Phase 1 clinical trial evaluating cord blood for sacroiliac joint syndrome treatment, signaling an early move into therapeutic applications beyond traditional transplant use.
Lifeforce Cryobanks firmographics
Firmographics- Name
- Lifeforce Cryobanks
- Legal name
- Cord for Life
- Website
- https://lifeforcecryobanks.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Lifeforce Cryobanks (operating as Cord for Life) is an Orlando-based private cord blood and cord tissue stem cell cryobank founded in 1995. It serves expectant parents with private family banking and public donation services using its proprietary PREMIERMAX® processing method at its FDA-accredited in-house laboratory.
- Ownership category
- akta.pro rank
Lifeforce Cryobanks industry classification
Industry- Product category
- Cord Blood and Cord Tissue Cryobanking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
Keywords
Where Lifeforce Cryobanks is headquartered
LocationHeadquarters
- HQ city
- Orlando
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Lifeforce Cryobanks business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Private Cord Blood Banking: Families pay for collection, processing, and ongoing storage of their newborn's cord blood and cord tissue for personal/family use. Annual storage fees apply for continued preservation.
- Public Cord Blood Donation: Families can donate cord blood to public inventory at no cost, supporting nationwide transplant efforts. Revenue generated through transplant matching fees when units are used.
- Imminent Need Program: Specialized program for families with a child or family member diagnosed with a disease treatable by stem cell transplant, providing discounted or subsidized services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Private cord blood banking services |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Lifeforce Cryobanks product offering
Product offeringCore offering
Lifeforce Cryobanks, operating as Cord for Life, preserves newborn stem cells from umbilical cord blood and cord tissue through its proprietary PREMIERMAX® processing method and in-house cryopreservation facility. It sells private family banking (collection kit, processing, and ongoing annual storage) and operates a public cord-blood donation program that supplies nationwide transplant inventory, with collection kits distributed via OBGYNs, midwives, and direct-to-consumer enrollment.
Differentiator
Problem solved
Functional benefit
Brands
- PREMIERMAX®: Proprietary processing method that focuses on quality, safety, flexibility, and cost in stem cell processing.
Products and services
- Private Cord Blood Banking Paid service for expectant parents in which newborn cord blood is collected at delivery using a kit provided by the company, processed in-house using the proprietary PREMIERMAX® method, and stored long-term in a private facility for the family's exclusive future use.
- Public Cord Blood Donation Free service for expectant parents who donate newborn cord blood to the company's public inventory, which is matched through the National Marrow Donor Program to patients needing stem cell transplants.
- Cord Tissue Banking Cryopreservation of stem cells from the umbilical cord tissue in addition to cord blood, offering families a broader set of preserved stem cell types for potential future therapeutic use.
- Imminent Need Program Discounted or subsidized cord blood and cord tissue banking service tailored for families with a child or family member already diagnosed with a disease treatable by stem cell transplant.
Quantifiable outcome
- Over 2,200 cord blood transplants facilitated since founding
- +1 more outcomes
Companies that use Lifeforce Cryobanks
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Lifeforce Cryobanks technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Lifeforce Cryobanks partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- National Marrow Donor ProgramcoreCord for Life participates in the National Marrow Donor Program as both a public cord blood bank and private banking service, facilitating stem cell releases for transplants and supporting the broader national registry for matching patients with donors.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Lifeforce Cryobanks competitors and assessment
Company assessmentDirect peers
- AlphaCord: AlphaCord is a private U.S. cord blood and tissue bank providing subscription-based storage plans to families — operating with a similar DTC enrollment model and in-house processing orientation as Lifeforce Cryobanks.
- New England Cord Blood Bank: New England Cord Blood Bank operates a U.S. cord blood banking program serving expectant parents and transplant centers, comparable to Lifeforce on processing services and clinical-grade storage standards.
- StemCyte: StemCyte operates as both a public cord blood bank and a private family bank — a hybrid model that mirrors Lifeforce's dual public/private structure, particularly its participation in the National Marrow Donor Program for transplant matching.
- ViaCord: ViaCord is a well-known U.S. private cord blood bank offering newborn stem cell storage to expectant parents; it competes directly for the same consumer segment and works with healthcare providers to distribute collection kits, paralleling Lifeforce's GTM motion.
- Cryo-Cell International: Cryo-Cell International is one of the largest U.S. private cord blood banks, offering both cord blood and cord tissue storage with multiple collection kit options — directly comparable to Lifeforce Cryobanks' core service offering of private family banking of cord blood and tissue.
- Americord Registry: Americord Registry is a U.S. cord blood and tissue bank serving expectant parents through online enrollment and provider partnerships, making it a direct competitor in private family banking with overlapping GTM (DTC + provider referrals).
- CorCell (formerly Maze Labs): CorCell is a private cord blood bank targeting expectant parents with subscription storage offerings, directly competing with Lifeforce in the consumer-facing family banking segment.
Regional players
- Cells4Life: Cells4Life is a leading UK-based private cord blood and tissue bank serving expectant parents in Europe — a comparable subscription-storage business model and product, though focused on a different geography.
Broad incumbents
- CBR (Cord Blood Registry) — legacy/legacy brand: Cord Blood Registry was historically the largest U.S. private cord blood bank; while ownership has shifted and the entity is no longer actively enrolling in the same way, it remains the historical benchmark competitor for scale and brand recognition in U.S. private cord blood banking.
- Versiti Blood Center of Wisconsin (Cord Blood): Versiti operates as a nonprofit blood center network that includes cord blood collection and public banking as part of broader hematology services — a broader incumbent in the same biological materials preservation space rather than a specialized private competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Lifeforce Cryobanks social profiles
Digital presenceLifeforce Cryobanks financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lifeforce Cryobanks leadership team
Management profileNumber of profiles
Profiles3 records
Lifeforce Cryobanks funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lifeforce Cryobanks M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lifeforce Cryobanks
What does Lifeforce Cryobanks do?
Lifeforce Cryobanks, operating as Cord for Life, preserves newborn stem cells from umbilical cord blood and cord tissue through its proprietary PREMIERMAX® processing method and in-house cryopreservation facility. It sells private family banking (collection kit, processing, and ongoing annual storage) and operates a public cord-blood donation program that supplies nationwide transplant inventory, with collection kits distributed via OBGYNs, midwives, and direct-to-consumer enrollment.
Is Lifeforce Cryobanks a public or private company?
Lifeforce Cryobanks is a private company. It is classified as unknown and is currently operating.
When was Lifeforce Cryobanks founded?
Lifeforce Cryobanks was founded in 1995. It employs 1 to 10 people.
Where is Lifeforce Cryobanks based?
Lifeforce Cryobanks is headquartered in Orlando, United States, in the North America region.
How does Lifeforce Cryobanks make money?
Three revenue lines are on record. Private Cord Blood Banking is the primary driver. The others are public Cord Blood Donation and imminent Need Program.
Who are Lifeforce Cryobanks's main competitors?
Direct peers on record are AlphaCord, New England Cord Blood Bank, StemCyte, ViaCord, Cryo-Cell International, Americord Registry and CorCell (formerly Maze Labs). Cells4Life is listed as a regional player. Broad incumbents are CBR (Cord Blood Registry) — legacy/legacy brand and Versiti Blood Center of Wisconsin (Cord Blood).
Does Lifeforce Cryobanks have an API?
No public API is recorded for Lifeforce Cryobanks.
What industry is Lifeforce Cryobanks in?
Lifeforce Cryobanks's product category is Cord Blood and Cord Tissue Cryobanking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 621991 and its SIC code is 2836.